Vaccine Strategies in Follicular Lymphoma

Joshua Brody, MD, assistant professor, Icahn School of Medicine, director, Lymphoma Immunotherapy Program, Mount Sinai Hospital, discusses vaccine strategies in follicular lymphoma.

Clinical Pearls

Joshua Brody, MD, assistant professor, Icahn School of Medicine, director, Lymphoma Immunotherapy Program, Mount Sinai Hospital, discusses vaccine strategies in follicular lymphoma. Brody presented on this topic at the 2014 Chemotherapy Foundation Symposium.

  • First generations of lymphoma vaccines looked promising, but were not efficacious enough to become standard therapies.
  • New lymphoma vaccines take a more holistic perspective — targeting any tumor-specific or tumor-associated antigens.

<<<

View more from the 2014 Chemotherapy Foundation Symposium